跳至主要内容
临床试验/NCT02026635
NCT02026635撤回不适用

Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in Heart Failure Patients (CONFIRM-HF)

Thomas Jefferson University1 个研究点 分布在 1 个国家开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Physician Use of Cardiac Compass Reports to Determine HF Treatment Decisions

研究概览

简要总结

A research study to determine if heart failure can be medically managed using data collected from cardiac monitoring devices

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years of age
  • Admission for worsening of HF
  • Discharged to home
  • Have appropriate cardiac device with OptiVol® implanted for at least 34 days prior to enrollment
  • Enrolled in Carelink® system and able to transmit data
  • Able to participate for at least 3 months

排除标准

  • Post heart transplant or actively listed
  • End-stage (Stage D) HF, including treatment with chronic ionotropic drugs or left ventricular assist device support
  • Stage IV or V chronic renal dysfunction (GFR <25 mol/min per 1.73 M2)
  • Severe Chronic Obstructive Pulmonary Disease (COPD) requiring home oxygen
  • Severe pulmonary hypertension not due to left-sided HF

结局指标

主要结局

Physician Use of Cardiac Compass Reports to Determine HF Treatment Decisions

时间窗: 90 days from enrollment

Assessment will be completed at time of enrollment and days 3 to 7, 14 to 21, 30 and 90 post discharge.

次要结局

  • Heart Failure Clinical Events(90 days from enrollment)
  • Assess Patient-Reported Quality of Life(90 days from enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Cardiac Compass With Optivol® to Negate Future... | 临床试验